Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
Ventuno Biotech has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Ventuno Biotech's investors include BNP Paribas, Relyens, Caisse d'Epargne Rhone Alpes, Octalfa, Armand Bensussan.
Ventuno Biotech is headquartered in Lyon, France.
Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
Ventuno Biotech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ventuno Biotech — Funding & Investors." VCBacked, November 26, 2025, https://www.vcbacked.co/company/ventuno-biotech. Accessed October 30, 2026.
VCBacked. (2025). Ventuno Biotech — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/ventuno-biotech
{{cite web |title=Ventuno Biotech — Funding & Investors |url=https://www.vcbacked.co/company/ventuno-biotech |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated